Waters, Labcorp Partner to Expand Access to FDA-Approved HPV Testing
Waters and Labcorp announced a partnership to expand access to an FDA-approved HPV testing option beginning in late 2026.
Story updates
12:01:33 PM UTC
SquawkNews
Waters and Labcorp announced a partnership to offer the FDA-approved BD Onclarity HPV Assay across Labcorp’s U.S. network beginning in late 2026, aiming to expand access to cervical cancer screening.Material DetailsContext by AI AnalystThis is an early-stage commercialization move following Waters’…